When John D. Abramson was practising family medicine in Hamilton, Mass., he prided himself on how conscientiously he selected the drugs that he prescribed. He closely followed pharmaceutical research. He kept track of the latest medical guidelines.

more...

Introducing a new drug to the market now costs an average of US$ 897 million and is a time consuming process. Discovering new uses for the old drugs offers the advantage of providing time tested drugs for the benefit of the patients.

more...

Treating HIV disease could become a lot easier for many people who are on a medication regimen. Two of the world's pharmaceutical giants--Bristol-Myers Squibb and Gilead Sciences--have teamed up to create the so-called holy grail of treatment:

more...

The US Food and Drug Administration is under intense pressure to shore up public confidence in the safety and quality of prescription drugs. Drug experts are scrutinizing the risks associated with long-term use of statins,

more...

TAP Pharmaceutical Products has agreed to pay the government a record $875 million to settle extensive civil and criminal charges of illegally marketing and manipulating the costs of Lupron, a prostate cancer drug, under the Medicare and Medicaid programs, the Department of Justice (DOJ) announced October 3, 2001.

more...